entertainment -WSS

entertainment

author：focus 2025-10-02 23:48:38 - browse：93

Sammy Kimball for STAT

Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally time for Novavax to shine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of prescription drug pricing. Then, STAT’s Helen Branswell calls in to walk us through a news-packed week for vaccines, including weighty decisions for Covid-19 and RSV.

For more on what we cover, here’s the story on conflicts of interest; here’s the latest on RSV vaccines; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： Why the Crimean Bridge is key to Russia's war in Ukraine

WSS

STAT reporters are Pulitzer Prize finalists for investigative reporting

How dance can help health care workers heal from trauma

Why some people catch Covid but never get sick

Why the Crimean Bridge is key to Russia's war in Ukraine

WuXi Biologics execs register to lobby as Congress comes for the company

STAT series 'Denied by AI' wins major journalism prizes

focus

entertainment

Wikipedia

New air purifier tech could be key to improving indoor air quality

Couple fighting to bring baby home from Mexico are finally reunited

Bright Health sells Medicare Advantage business to Molina

Novo Nordisk testing Wegovy against alcohol

The cancer drug shortage isn’t new — and neither are the solutions

The kidney, in all its complexity, is captured in a new atlas

New air purifier tech could be key to improving indoor air quality

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Virginia high school admissions case could be legal follow

Lilly’s weekly insulin works as well as daily products, new studies show

entertainment

TikTok cracks down on users posting about weight loss drugs

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

ALS treatment from Biogen, Ionis fails in study

Why the Crimean Bridge is key to Russia's war in Ukraine

TikTok cracks down on users posting about weight loss drugs

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

focus

focus

focus

explore